{
  "attach_pages": "26",
  "attach_size": "3167",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201903281310989934_1.pdf?1601214722000.pdf",
  "company_code": "80000118",
  "eitime": "2019-03-28 21:43:39",
  "extend": {},
  "info_code": "AP201903281310989934",
  "language": "0",
  "notice_date": "2019-03-28 00:00:00",
  "notice_title": "【联讯医药公司深度研究报告】天坛生物：未来已来，预期逐渐向好的血制央企",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "BB",
  "researcher": "李志新",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "1044",
          "publishName": "生物制品"
        }
      ],
      "short_name": "天坛生物",
      "short_name_ch": "天坛生物",
      "short_name_cht": "天壇生物",
      "short_name_en": "BTBP",
      "stock": "600161"
    }
  ],
  "short_name": "天坛生物",
  "source_sample_name": "粤开证券",
  "star": "3"
}